ArticleFrontiers in medicine2026

Neoadjuvant pyrotinib for HER2 (IHC 2+/FISH+)/HR+ breast cancer with early non-response: a case report and literature review.

Jiani Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.